Using CYP2D6 genotype to understand paroxetine-pimozide pharmacokinetics in man

被引：0
|
作者：
Foot, Elizabeth [1 ]
Briley, Linda [1 ]
McCarthy, Linda [1 ]
Moate, Rachel [1 ]
Reck, Brian [1 ]
Muir, Keith [1 ]
Stapleton, Carole [1 ]
Cox, Charles [1 ]
Dow, David [1 ]
Mehta, Nalini [1 ]
Latham, Ian [1 ]
Goodgame, Neil [1 ]
Vousden, Marika [1 ]
Nucci, Gianluca [1 ]
机构：
[1] GlaxoSmithKline Inc, Greenford, Middx, England
来源：
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS | 2006年 / 141B卷 / 07期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：786 / 786
页数：1
相关论文
共 50 条
  • [21] The relationship between plasma concentration of paroxetine and CYP2D6 genotype in Japanese psychiatric patients
    Ueda, M
    Hirokane, G
    Morita, S
    Yokono, A
    Okawa, M
    Shimoda, K
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S223 - S223
  • [22] Assessment of Activity Levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 Genes by Population Pharmacokinetics of Dextromethorphan
    Abduljalil, K.
    Frank, D.
    Gaedigk, A.
    Klaassen, T.
    Tomalik-Scharte, D.
    Jetter, A.
    Jaehde, U.
    Kirchheiner, J.
    Fuhr, U.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (05) : 643 - 651
  • [23] CYP2D6 genotype and tamoxifen response
    James M Rae
    Matthew P Goetz
    Daniel F Hayes
    James N Ingle
    Lang Li
    Anna Maria Storniolo
    Vered Stearns
    David A Flockhart
    Breast Cancer Research, 7
  • [24] CYP2D6 Genotype and Adjuvant Tamoxifen
    Berry, D. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (02) : 138 - 140
  • [25] Metabolism of antipsychotics and CYP2D6 genotype
    Schmider, J
    Walter, S
    Sachse, C
    Bauer, S
    Müller-Oerlinghausen, B
    Roots, I
    Brockmöller, J
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R459 - R459
  • [26] CYP2D6 genotype and tardive dyskinesia
    Sajjad, SHA
    BRITISH JOURNAL OF PSYCHIATRY, 1997, 170 : 580 - 580
  • [27] CYP2D6 genotype and tamoxifen response
    Rae, JM
    Goetz, MP
    Hayes, DF
    Ingle, JN
    Li, L
    Storniolo, AM
    Stearns, V
    Flockhart, DA
    BREAST CANCER RESEARCH, 2005, 7 (05)
  • [28] CONCORDANCE OF PHENOTYPE AND GENOTYPE FOR CYP2D6
    MCLEOD, HL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 56 (04) : 463 - 463
  • [29] Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors
    Gressier, F.
    Verstuyft, C.
    Hardy, P.
    Becquemont, L.
    Corruble, E.
    JOURNAL OF NEURAL TRANSMISSION, 2015, 122 (01) : 35 - 42
  • [30] Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors
    F. Gressier
    C. Verstuyft
    P. Hardy
    L. Becquemont
    E. Corruble
    Journal of Neural Transmission, 2015, 122 : 35 - 42
12345